The Psychedelic Revolution Is Coming. Psychiatry May Never Be the Same.
Psilocybin and MDMA are poised to be the hottest new therapeutics since Prozac. Universities want in, and so does Wall Street. Some worry a push to loosen access could bring unintended consequences. By Andrew Jacobs Published May 9, 2021Updated May 12, 2021 It’s been a long, strange trip in the four decades since Rick Doblin, a pioneering psychedelics…